Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
(Z)-Endoxifen + Goserelin in Premenopausal ER+/HER2- Breast Cancer
NCT05607004Phase 2Active, not recruiting
- Sponsor
- Atossa Therapeutics
- Start
- Feb 2023
- Primary completion
- Nov 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of z-endoxifen in breast cancer, sponsored by Atossa Therapeutics. Started Feb 2023; status: active, not recruiting.
02
Drugs
z-endoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT05607004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05607004.